However, in the CODRP index-based drug sensitivity test, drug sensitivity was predicted as a high resistance group with a CODRP index Z-score value of ≥ 1.79 for all three ALK-targeted drugs due to high cancer stage and rapid cell growth rate (Fig. 9B). The gene discussed is ALK; the disease is cancer.